A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease
Gottlieb, DJ, Brenner, MK, Heslop, HE, Bianchi, ACM, Bello-Fernandez, C, Mehta, AB, Newland, AC, Galazka, AR, Scott, EM, Hoffbrand, AVТом:
60
Рік:
1989
Мова:
english
Сторінки:
6
DOI:
10.1038/bjc.1989.324
Файл:
PDF, 1.01 MB
english, 1989